EuroCardioOnc's profile picture. The European Cardio-Oncology Symposium (ECOS) is a CME initiative supporting cardiologists and oncologists interested in #CardioOnc

EuroCardio-Onc

@EuroCardioOnc

The European Cardio-Oncology Symposium (ECOS) is a CME initiative supporting cardiologists and oncologists interested in #CardioOnc

Angepinnt

Thanks to everyone who joined us for the 2nd webinar in the Virtual Grand Rounds series! A great discussion with practical #anticoagulation strategies for patients with #cancer and #Afib #CardioOncology #cardiology #oncology #haematology #CardioTwitter #MedEd

EuroCardioOnc's tweet image. Thanks to everyone who joined us for the 2nd webinar in the Virtual Grand Rounds series! A great discussion with practical #anticoagulation strategies for patients with #cancer and #Afib  #CardioOncology #cardiology #oncology #haematology #CardioTwitter #MedEd

EuroCardio-Onc hat repostet

Calling all #CardioOnc enthusiasts. A great day of in person learning for trainees, AHPs and consultants in oncology and cardiology. A practical day covering common #cardiooncology issues! @ICOSociety @BCOSCardioOnc @BSHeartFailure @WilsonAndrewDr @mdstbarts @BartsHospital

Course Directors @arjunkg @ShouvikHaldar, Professor Stuart Rosen, Dr Rebecca Roylance and Dr Andrew Wilson have brought together a fantastic line-up of speakers covering ACS and cardiac issues in cancer patients, new ESC guidelines, cardiac devices and radiotherapy and more.



Congrats @sdent_duke! 👏👏👏 Amazing leadership in #CardioOnc!

The incomparable @sdent_duke the 2022 Thomas Force Leadership In #CardioOncology Award presented by Bonnie Ky the 2021 winner. No one more deserved of this honor. #cardioonc #gcos2022 @DukeCardiology @DukeCancerNETWK

Dr_Mike_Fradley's tweet image. The incomparable @sdent_duke the 2022 Thomas Force Leadership In #CardioOncology Award presented by Bonnie Ky the 2021 winner.  No one more deserved of this honor.  #cardioonc #gcos2022 @DukeCardiology @DukeCancerNETWK
Dr_Mike_Fradley's tweet image. The incomparable @sdent_duke the 2022 Thomas Force Leadership In #CardioOncology Award presented by Bonnie Ky the 2021 winner.  No one more deserved of this honor.  #cardioonc #gcos2022 @DukeCardiology @DukeCancerNETWK
Dr_Mike_Fradley's tweet image. The incomparable @sdent_duke the 2022 Thomas Force Leadership In #CardioOncology Award presented by Bonnie Ky the 2021 winner.  No one more deserved of this honor.  #cardioonc #gcos2022 @DukeCardiology @DukeCancerNETWK


EuroCardio-Onc hat repostet

Congratulations to the formidable @sdent_duke for receiving the Thomas force leadership award. Giving her thoughts on the scientific challenges for #cardiooncology field #GCOS2022

erin_howden's tweet image. Congratulations to the formidable @sdent_duke for receiving the Thomas force leadership award. Giving her thoughts on the scientific challenges for #cardiooncology field #GCOS2022

EuroCardio-Onc hat repostet

Listen to Drs. Alexander R Lyon and @TeresaLpezFdez1 talk about the top key messages about the 2022 @escardio Guidelines on #CardioOnc. #GCOS2022 #CardioEd #CardioTwitter


EuroCardio-Onc hat repostet

UCSF #CardioOnc conference this week! @AmirZMunir presenting on RAF/MEKi Cardiotoxicity. Welcoming back @UCSF_CVfellows graduate & @UNC_SOM Prof Brian Jensen! @ethanjweiss @avirupguha @MandarArasMD @baik_alan @drycm2d @EimanJahangir @NovartisCancer @JayaMallidi @WCFWMeijers

CardioOncology's tweet image. UCSF #CardioOnc conference this week! @AmirZMunir presenting on RAF/MEKi Cardiotoxicity. Welcoming back @UCSF_CVfellows graduate & @UNC_SOM Prof Brian Jensen! @ethanjweiss @avirupguha @MandarArasMD @baik_alan @drycm2d @EimanJahangir @NovartisCancer @JayaMallidi @WCFWMeijers

We can’t wait to learn more about the new @ESCardio #CardioOnc guidelines.👍😀 What are you most looking forward to at #ESCCongress 2022?

EuroCardioOnc's tweet image. We can’t wait to learn more about the new @ESCardio #CardioOnc guidelines.👍😀

What are you most looking forward to at #ESCCongress 2022?

EuroCardio-Onc hat repostet

Weekly webinar: Best Practices: Cardio-Oncology in Nursing 21 APR 9:00 AM EST register: wondrmedical.net/ch/IC-OS/event… speaker: Vicki Chambers @KerrySkurka @AnecitaFadol


EuroCardio-Onc hat repostet

Cardiovascular conditions and obesity among gynecologic cancer survivors: Results from the 2020 behavioral risk factor surveillance system survey sciencedirect.com/science/articl… #cardioonc great collaboration with @MCG_AUG @GACancerCenter colleagues using @BRFSS


EuroCardio-Onc hat repostet

The effect of trastuzumab on cardiac function in patients with a baseline LVEF of 40-49%. In sum, 35% had a further decline in LVEF and of those, 50% did not fully recover. Recovery helped by GDMT. A valuable paper to help inform risk/benefit. pubmed.ncbi.nlm.nih.gov/35403708/


EuroCardio-Onc hat repostet

Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study | Journal of Clinical Oncology - Hot off the press describing risk of cvd in long term breast cancer survivors ⁦@JamalRanaMD⁩ ⁦@marilyn_kwanascopubs.org/doi/10.1200/JC…


EuroCardio-Onc hat repostet

Come join us on webinar this am: Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients with Immune Checkpoint Inhibitor-Associated Myocarditis. 9am EST. Register: wondrmedical.net/ch/IC-OS/event… by @RajaZaghlol


EuroCardio-Onc hat repostet

Prospective Observation of Cardiac Safety with Proteasome Inhibitor by Dr. Daniel Lenihan, MD Read More: loom.ly/xa7ZtJ8 #cardioonc #cardiooncology

CCardiacON's tweet image. Prospective Observation of Cardiac Safety with Proteasome Inhibitor by Dr. Daniel Lenihan, MD
 
Read More: loom.ly/xa7ZtJ8 #cardioonc #cardiooncology

The recordings from the Virtual Grand Rounds series of live #webinars on practical #anticoagulation strategies for patients with #cancer are now available to view online: bit.ly/36EITAp #CardioOnc #oncology #MedEd #MedTwitter #CME @arjunkg @oncology_cardio @avirupguha


EuroCardio-Onc hat repostet

Effects of #Dapagliflozin in Asian Patients With #HFrEF in DAPA-HF Of the 4,744 patients in the #DAPA-HF trial, 1,096 (23.1%) were enrolled in Asia Evidence of a consistent benefit and safety of the #SGLT2i in Asian , as compared with patients from outside Asia @JACCJournals

HanCardiomd's tweet image. Effects of #Dapagliflozin in Asian Patients With #HFrEF in DAPA-HF

Of the 4,744 patients in the #DAPA-HF trial, 1,096 (23.1%) were enrolled in Asia 

Evidence of a consistent benefit and safety of the #SGLT2i in Asian , as compared with patients from outside Asia

@JACCJournals
HanCardiomd's tweet image. Effects of #Dapagliflozin in Asian Patients With #HFrEF in DAPA-HF

Of the 4,744 patients in the #DAPA-HF trial, 1,096 (23.1%) were enrolled in Asia 

Evidence of a consistent benefit and safety of the #SGLT2i in Asian , as compared with patients from outside Asia

@JACCJournals
HanCardiomd's tweet image. Effects of #Dapagliflozin in Asian Patients With #HFrEF in DAPA-HF

Of the 4,744 patients in the #DAPA-HF trial, 1,096 (23.1%) were enrolled in Asia 

Evidence of a consistent benefit and safety of the #SGLT2i in Asian , as compared with patients from outside Asia

@JACCJournals

EuroCardio-Onc hat repostet

If you missed our Amyloidosis Month Webinar with @FranceFound here is the link to view all 4 of them: bit.ly/3LmhZM3

ICOSociety's tweet image. If you missed our Amyloidosis Month Webinar with @FranceFound here is the link to view all 4 of them:  bit.ly/3LmhZM3
ICOSociety's tweet image. If you missed our Amyloidosis Month Webinar with @FranceFound here is the link to view all 4 of them:  bit.ly/3LmhZM3

Loading...

Something went wrong.


Something went wrong.